Clinical Trial Update: Investigating a Marijuana-based Compound as a Treatment for Anxiety in Autistic Adults [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study assessing a marijuana-derived cannabinoid for anxiety in autistic adults, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety
• Autism Spectrum Disorder

Drugs mentioned

• Marijuana-based cannabinoid compound

Snippet

Sponsor: Southwest Autism Research & Resource Center | Conditions: Autism Spectrum Disorder, Anxiety | Phase 2 | Status: RECRUITING